Literature DB >> 19439546

Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.

N C Gordon1, D W Wareham.   

Abstract

CHROMagar Acinetobacter was used to screen stool and perineal swabs for enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. Results were compared with a molecular assay resulting in sensitivity and specificity of culture compared to PCR of 91.7% and 89.6%, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439546      PMCID: PMC2708470          DOI: 10.1128/JCM.00634-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii.

Authors:  C Agustí; M Pujol; M J Argerich; J Ayats; M Badía; M A Domínguez; X Corbella; J Ariza
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

Review 2.  Impact of selective decontamination of the digestive tract on carriage and infection due to Gram-negative and Gram-positive bacteria: a systematic review of randomised controlled trials.

Authors:  L Silvestri; H K F van Saene; A Casarin; G Berlot; A Gullo
Journal:  Anaesth Intensive Care       Date:  2008-05       Impact factor: 1.669

3.  Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation.

Authors:  Mark Wilks; Anne Wilson; Simon Warwick; Elizabeth Price; Daniel Kennedy; Andrew Ely; Michael R Millar
Journal:  Infect Control Hosp Epidemiol       Date:  2006-06-20       Impact factor: 3.254

4.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

5.  Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii.

Authors:  X Corbella; M Pujol; J Ayats; M Sendra; C Ardanuy; M A Domínguez; J Liñares; J Ariza; F Gudiol
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

6.  Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance.

Authors:  D W Wareham; D C Bean; P Khanna; E M Hennessy; D Krahe; A Ely; M Millar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-19       Impact factor: 3.267

Review 7.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

Authors:  Lisa L Maragakis; Trish M Perl
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

8.  Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit.

Authors:  M Denton; M H Wilcox; P Parnell; D Green; V Keer; P M Hawkey; I Evans; P Murphy
Journal:  J Hosp Infect       Date:  2004-02       Impact factor: 3.926

9.  Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii.

Authors:  J F Turton; S N Gabriel; C Valderrey; M E Kaufmann; T L Pitt
Journal:  Clin Microbiol Infect       Date:  2007-08       Impact factor: 8.067

10.  Decontamination of the digestive tract and oropharynx in ICU patients.

Authors:  A M G A de Smet; J A J W Kluytmans; B S Cooper; E M Mascini; R F J Benus; T S van der Werf; J G van der Hoeven; P Pickkers; D Bogaers-Hofman; N J M van der Meer; A T Bernards; E J Kuijper; J C A Joore; M A Leverstein-van Hall; A J G H Bindels; A R Jansz; R M J Wesselink; B M de Jongh; P J W Dennesen; G J van Asselt; L F te Velde; I H M E Frenay; K Kaasjager; F H Bosch; M van Iterson; S F T Thijsen; G H Kluge; W Pauw; J W de Vries; J A Kaan; J P Arends; L P H J Aarts; P D J Sturm; H I J Harinck; A Voss; E V Uijtendaal; H E M Blok; E S Thieme Groen; M E Pouw; C J Kalkman; M J M Bonten
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

View more
  12 in total

1.  Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.

Authors:  V C C Cheng; J H K Chen; S Y C So; S C Y Wong; M K Yan; P H Chau; W M Lee; K K W To; J F W Chan; I F N Hung; P L Ho; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-15       Impact factor: 3.267

Review 2.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.

Authors:  J Moran-Gilad; A Adler; D Schwartz; S Navon-Venezia; Y Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-28       Impact factor: 3.267

4.  Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients.

Authors:  A O Ajao; G Robinson; M S Lee; T D Ranke; R A Venezia; J P Furuno; A D Harris; J K Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

5.  Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

Authors:  José Garnacho-Montero; George Dimopoulos; Garyphallia Poulakou; Murat Akova; José Miguel Cisneros; Jan De Waele; Nicola Petrosillo; Harald Seifert; Jean François Timsit; Jordi Vila; Jean-Ralph Zahar; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2015-10-05       Impact factor: 17.440

6.  Expression pattern of soluble triggering receptor expressed on myeloid cells-1 in mice with Acinetobacter baumannii colonization and infection in the lung.

Authors:  Chengping Hu; Juan Jiang; Zhen Li; Yuanyuan Li
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii.

Authors:  Michael Hornsey; David W Wareham
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

Review 8.  Carbapenem Resistance: A Review.

Authors:  Francis S Codjoe; Eric S Donkor
Journal:  Med Sci (Basel)       Date:  2017-12-21

9.  Modified CHROMagar Acinetobacter medium for direct detection of multidrug-resistant Acinetobacter strains in nasal and rectal swab samples.

Authors:  Wonkeun Song; Jacob Lee; Taek-Kyung Kim; Min-Jeong Park; Han-Sung Kim; Jae-Seok Kim
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

10.  Rapid identification of nosocomial Acinetobacter baumannii isolated from a surgical intensive care unit in Egypt.

Authors:  Doaa Mohammad Ghaith; Reem Mostafa Hassan; Ahmed Mohamed Hasanin
Journal:  Ann Saudi Med       Date:  2015 Nov-Dec       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.